HQY

81.02

0.14% -0.11

Dopo l'orario di chiusura: 81.02

Healthequity Inc (HQY)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HQY Giù? Forum Previsione

Precedente Chiudi:

$81.13

Aprire:

$81.06

Volume 24 ore:

1.30M

Relative Volume:

1.34

Capitalizzazione di mercato:

$6.84B

Reddito:

$1.31B

Utile/perdita netta:

$215.20M

Rapporto P/E:

32.90

EPS:

2.4627

Flusso di cassa netto:

$408.32M

1 W Prestazione:

+4.13%

1M Prestazione:

+2.69%

6M Prestazione:

-13.57%

1 anno Prestazione:

-4.23%

Intervallo 1D:

$79.79

$82.03

Intervallo di 1 settimana:

$77.72

$83.36

Portata 52W:

$72.76

$116.65

Healthequity Inc Stock (HQY) Company Profile

Nome

Healthequity Inc

Settore

Healthcare (1110)

Industria

Health Information Services (49)

Telefono

801-727-1000

Indirizzo

15 WEST SCENIC POINTE DRIVE, DRAPER, UT

Dipendente

2,814

Cinguettio

@healthequity

Prossima data di guadagno

2026-03-17

Ultimi documenti SEC

HQY's Discussions on Twitter

Compare HQY vs VEEV, TEM, BTSG, MMED

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HQY Healthequity Inc	81.02	6.84B	1.31B	215.20M	408.32M	2.4627
VEEV Veeva Systems Inc	184.07	30.26B	3.20B	908.91M	1.42B	5.4155
TEM Tempus Ai Inc	46.96	8.40B	1.27B	-245.03M	-245.36M	-1.4071
BTSG Brightspring Health Services Inc	41.21	7.92B	12.91B	104.80M	394.69M	0.8769
MMED Minimed Group Inc	16.57	4.65B	0	0	0	0.00

Healthequity Inc Stock (HQY) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-09	Downgrade	Goldman	Neutral → Sell
2025-12-09	Iniziato	Barclays	Overweight
2025-11-13	Iniziato	BMO Capital Markets	Market Perform
2025-05-22	Ripresa	RBC Capital Mkts	Outperform
2025-03-25	Aggiornamento	Raymond James	Outperform → Strong Buy
2024-12-04	Iniziato	Mizuho	Outperform
2024-11-15	Iniziato	Goldman	Neutral
2024-04-04	Iniziato	JMP Securities	Mkt Outperform
2024-04-02	Reiterato	JP Morgan	Overweight
2024-01-03	Iniziato	Barclays	Overweight
2023-09-21	Aggiornamento	Robert W. Baird	Neutral → Outperform
2022-10-21	Aggiornamento	Goldman	Sell → Neutral
2022-09-16	Iniziato	KeyBanc Capital Markets	Overweight
2022-07-12	Iniziato	Goldman	Sell
2022-04-11	Iniziato	Wells Fargo	Overweight
2022-04-07	Iniziato	Guggenheim	Buy
2022-03-30	Aggiornamento	BTIG Research	Neutral → Buy
2021-12-07	Downgrade	Raymond James	Strong Buy → Outperform
2021-12-02	Iniziato	Jefferies	Buy
2021-09-09	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2021-07-02	Iniziato	Stephens	Overweight
2021-04-29	Ripresa	JP Morgan	Overweight
2021-01-07	Iniziato	BTIG Research	Neutral
2020-12-08	Reiterato	Barrington Research	Outperform
2020-12-02	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2020-11-23	Downgrade	Guggenheim	Buy → Neutral
2020-10-23	Iniziato	RBC Capital Mkts	Outperform
2020-04-14	Iniziato	Guggenheim	Buy
2020-04-13	Iniziato	SVB Leerink	Mkt Perform
2020-03-17	Reiterato	Barrington Research	Outperform
2019-10-07	Iniziato	Goldman	Neutral
2019-09-09	Aggiornamento	Raymond James	Outperform → Strong Buy
2019-07-19	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-06-05	Reiterato	BofA/Merrill	Neutral
2019-03-01	Reiterato	BofA/Merrill	Neutral
2019-02-07	Reiterato	Chardan Capital Markets	Buy
2019-02-07	Aggiornamento	SunTrust	Hold → Buy
2018-12-06	Downgrade	SunTrust	Buy → Hold
2018-09-06	Downgrade	BofA/Merrill	Buy → Neutral
2018-05-23	Iniziato	BofA/Merrill	Buy
2018-04-24	Ripresa	JP Morgan	Overweight
2018-03-20	Reiterato	Chardan Capital Markets	Buy
2017-12-06	Reiterato	Chardan Capital Markets	Buy

Mostra tutto

Healthequity Inc Borsa (HQY) Ultime notizie

Mar 20, 2026

HealthEquity Inc stock faces scrutiny amid slowing HSA growth and rising competition in US benefits - AD HOC NEWS

Mar 20, 2026

HealthEquity (NASDAQ:HQY) Price Target Raised to $128.00 at Deutsche Bank Aktiengesellschaft - MarketBeat

Mar 19, 2026

Analysts Offer Insights on Healthcare Companies: Healthequity (HQY) and Intuitive Surgical (ISRG) - The Globe and Mail

Mar 19, 2026

Discipline and Rules-Based Execution in HQY Response - Stock Traders Daily

Mar 19, 2026

Deutsche Bank Adjusts HealthEquity Price Target to $128 From $120, Maintains Buy Rating - marketscreener.com

Mar 19, 2026

Analysts’ Top Healthcare Picks: Healthequity (HQY), AbSci (ABSI) - The Globe and Mail

Mar 19, 2026

BMO Maintains Market Perform on HealthEquity (HQY) March 18, 2026 - Meyka

Mar 19, 2026

Mar 18, 2026

HealthEquity Inc. Earnings Call Highlights Profitable Growth - TipRanks

Mar 18, 2026

Reasons to hold HealthEquity stock in your portfolio for now - MSN

Mar 18, 2026

HealthEquity (HQY) Margin Expansion To 16.4% Tests Bearish Cost Narratives - simplywall.st

Mar 18, 2026

HealthEquity Q4 Earnings Call Highlights - MarketBeat

Mar 18, 2026

New health sharing program has seen 236% growth rate, with high hopes for 2026 - AOL.com

Mar 18, 2026

HealthEquity (HQY): Analyst Lowers Price Target Amid Maintained Rating | HQY Stock News - GuruFocus

Mar 18, 2026

JP Morgan Maintains Rating, Lowers Price Target for HealthEquity (HQY) | HQY Stock News - GuruFocus

Mar 18, 2026

HealthEquity stock price target lowered to $100 by RBC on yield outlook - Investing.com India

Mar 18, 2026

JPMorgan Chase & Co. Issues Pessimistic Forecast for HealthEquity (NASDAQ:HQY) Stock Price - MarketBeat

Mar 18, 2026

HealthEquity (NASDAQ:HQY) Given New $110.00 Price Target at Barrington Research - MarketBeat

Mar 18, 2026

HQY: RBC Capital Maintains Outperform Rating, Lowers Price Targe - GuruFocus

Mar 18, 2026

HealthEquity, Inc. 2026 Annual Report: Technology-Driven HSA Solutions, Competitive Strategy, AI Innovation, and Risk Factors 232527293940 - Minichart

Mar 18, 2026

BMO reiterates HealthEquity stock rating on strong quarter, AI progress - Investing.com UK

Mar 18, 2026

BMO reiterates HealthEquity stock rating on strong quarter, AI progress By Investing.com - Investing.com India

Mar 18, 2026

Royal Bank Of Canada Has Lowered Expectations for HealthEquity (NASDAQ:HQY) Stock Price - MarketBeat

Mar 18, 2026

HealthEquity, Inc. Q4 2026 Earnings Call Summary - Yahoo Finance

Mar 18, 2026

HealthEquity (HQY) Q4 EPS Plunges 42.6% YoY to $0.95, Misses Estimates Despite $334.6M Revenue Beat - AlphaStreet

Mar 18, 2026

RBC Cuts Price Target on HealthEquity to $100 From $110, Keeps Outperform Rating - marketscreener.com

Mar 18, 2026

Faithward Advisors Boosts HealthEquity Stake to $4.41 Million - National Today

Mar 18, 2026

Faithward Advisors LLC Takes $4.41 Million Position in HealthEquity, Inc. $HQY - MarketBeat

Mar 18, 2026

HQY SEC FilingsHealthequity Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 18, 2026

Crown Advisors Management Inc. Invests $1.90 Million in HealthEquity, Inc. $HQY - MarketBeat

Mar 18, 2026

HealthEquity: Attractive Given Improved Cash Economics (Rating Upgrade) - Seeking Alpha

Mar 18, 2026

Healthequity Inc earnings beat by $0.05, revenue topped estimates - Investing.com Australia

Mar 18, 2026

HealthEquity (HQY) beats Q4 earnings and revenue estimates - MSN

Mar 18, 2026

Decoding HealthEquity Inc (HQY): A Strategic SWOT Insight - GuruFocus

Mar 18, 2026